No abstract available
MeSH terms
-
Anticoagulants / therapeutic use
-
Betacoronavirus*
-
Biomarkers / blood
-
Blood Coagulation Disorders / blood*
-
Blood Coagulation Disorders / virology
-
COVID-19
-
Case-Control Studies
-
Coronavirus Infections / blood
-
Coronavirus Infections / complications*
-
Fibrin Fibrinogen Degradation Products / metabolism*
-
Heparin, Low-Molecular-Weight / therapeutic use
-
Humans
-
Pandemics
-
Partial Thromboplastin Time
-
Pneumonia, Viral / blood
-
Pneumonia, Viral / complications*
-
Risk Factors
-
SARS-CoV-2
-
Thrombophilia / blood*
-
Thrombophilia / virology
-
Venous Thromboembolism / blood*
-
Venous Thromboembolism / drug therapy
-
Venous Thromboembolism / virology
Substances
-
Anticoagulants
-
Biomarkers
-
Fibrin Fibrinogen Degradation Products
-
Heparin, Low-Molecular-Weight
-
fibrin fragment D